RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:One more . . :-)Wow you really don't get it. We are where we are because of MEANINGFUL news. Trial results being the catalyst bringing us up from pennies to dollar valuation. Nothing other than the collaboration with 2 pharma was released after that and is now baked into the price. Pretty silly on Phils part to agree to not release the names or else we'd likely be trading higher. Now that we are here, we are unlikely to drop below 1.20 or go above above 2 dollars until the next MEANINGFUL news release. You don't need to be a pro to play the swings between, you just need a few more brain cells than you have.
It's not my job to educate you, but try to find a single stock that uplisted by way of a rollback and then remained successful. This exercise alone should make it pretty obvious why it's not a great plan. Listing on Nasdaq is not the holy grail you make it out to be hoping for your big boys to come play. The stock is trading at 1.55 because that is what the market feels it is worth. WIthout news convincing us otherwise, there won't be significant price changes.